Anchor Therapeutics, Inc. - Product Pipeline Review - 2015

Date: September 9, 2015
Pages: 27
Price:
US$ 1,500.00
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AD94555D6A5EN
Leaflet:

Download PDF Leaflet

Anchor Therapeutics, Inc. - Product Pipeline Review - 2015
Anchor Therapeutics, Inc. - Product Pipeline Review - 2015

SUMMARY

Global Markets Direct’s, ‘Anchor Therapeutics, Inc. - Product Pipeline Review - 2015’, provides an overview of the Anchor Therapeutics, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Anchor Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • The report provides brief overview of Anchor Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Anchor Therapeutics, Inc.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Anchor Therapeutics, Inc.’s pipeline products
REASONS TO BUY
  • Evaluate Anchor Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Anchor Therapeutics, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Anchor Therapeutics, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Anchor Therapeutics, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Anchor Therapeutics, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Anchor Therapeutics, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues
Anchor Therapeutics, Inc. Snapshot
Anchor Therapeutics, Inc. Overview
Key Information
Key Facts
Anchor Therapeutics, Inc. - Research and Development Overview
Key Therapeutic Areas
Anchor Therapeutics, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Anchor Therapeutics, Inc. - Pipeline Products Glance
Anchor Therapeutics, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Anchor Therapeutics, Inc. - Drug Profiles
ANC-39
Product Description
Mechanism of Action
R&D Progress
ATI-2341
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptide 1 to Modulate GPCR for Oncology
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptide 1 to Modulate GPCR for Inflammation
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptide 2 to Modulate GPCR for Inflammation
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptide 2 to Modulate GPCR for Oncology
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptide to Modulate Apelin Receptor for Cardiovascular Disorders
Product Description
Mechanism of Action
R&D Progress
Synthetic Peptides to Modulate GPR81 for Metabolic Disorders
Product Description
Mechanism of Action
R&D Progress
Anchor Therapeutics, Inc. - Pipeline Analysis
Anchor Therapeutics, Inc. - Pipeline Products by Target
Anchor Therapeutics, Inc. - Pipeline Products by Molecule Type
Anchor Therapeutics, Inc. - Pipeline Products by Mechanism of Action
Anchor Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Anchor Therapeutics, Inc., Key Information
Anchor Therapeutics, Inc., Key Facts
Anchor Therapeutics, Inc. - Pipeline by Indication, 2015
Anchor Therapeutics, Inc. - Pipeline by Stage of Development, 2015
Anchor Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
Anchor Therapeutics, Inc. - Preclinical, 2015
Anchor Therapeutics, Inc. - Discovery, 2015
Anchor Therapeutics, Inc. - Pipeline by Target, 2015
Anchor Therapeutics, Inc. - Pipeline by Molecule Type, 2015
Anchor Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2015

LIST OF FIGURES

Anchor Therapeutics, Inc. - Pipeline by Top 10 Indication, 2015
Anchor Therapeutics, Inc. - Pipeline by Stage of Development, 2015
Anchor Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
Anchor Therapeutics, Inc. - Pipeline by Top 10 Target, 2015
Anchor Therapeutics, Inc. - Pipeline by Top 10 Molecule Type, 2015
Anchor Therapeutics, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Skip to top


Ask Your Question

Anchor Therapeutics, Inc. - Product Pipeline Review - 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: